Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

29 June 2012

Repeated graft loss after orthotopic liver transplantation: A case report

Oskar KornasiewiczACDEF, Karol ZbrońskiABCE, Michał GrątABC, Krzysztof ZieniewiczD, Marek KawczykAG

DOI: 10.12659/AOT.883232

Ann Transplant 2012; 17(2): 131-134

Abstract

Background: Multiple orthotopic liver transplantations (OLTx), although relatively uncommon, are the only known therapy for repeated graft failure. Moreover, re-transplantation (re-OLTx) of more than 2 grafts is sparsely reported thus far.
Case Report: We describe here 2 cases of patients who fulfilled the criteria for undergoing more than 2 OLTx. Each patient received 3 grafts in total. The primary early indication for the first re-OLTx in both cases was hepatic artery thrombosis (HAT). Prior to the second re-OLTx, both patients were in poor general condition. In 1 case, the second graft failed due to the recurrence of primary sclerosing cholangitis; the patient was re-transplanted electively 69 months after the primary re-OLTx. In the other case, the patient required a non-elective second re-OLTx within 1 month after the first re-OLTx due to primary graft failure. In both patients, the second and the third re-OLTs were performed using a veno-venous bypass with hepaticojejunostomy on an already existing Roux-en-Y loop. While 1 patient died postoperatively due to multi-organ failure, the other is alive with good synthetic liver function at 60 months after the last transplantation. The overall mortality rate of this procedure was thus 50%.
Conclusions: Although repeated OLT of more than 2 grafts is technically feasible and in selected patients can be a life-saving procedure, it is rarely performed. In our limited experience, it is burdened with relatively high mortality and morbidity, unspecified indications regarding patient selection, and competition between patients awaiting liver transplantation.

Keywords: hepatic artery thrombosis, re-transplantation, primary nonfunction

Add Comment 0 Comments

In Press

Original article  

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Ann Transplant In Press; DOI: 10.12659/AOT.944762  

Original article  

Risk Factors for Graft Failure After Penetrating Keratoplasty in Eastern China from 2018 to 2021

Ann Transplant In Press; DOI: 10.12659/AOT.945388  

Original article  

Predictive Model for Post-Transplant Renal Fibrosis Using Ultrasound Shear Wave Elastography

Ann Transplant In Press; DOI: 10.12659/AOT.945699  

Original article  

The Long-Acting Glucagon-Like Peptide-2 Analog Apraglutide Enhances Intestinal Protection and Survival Afte...

Ann Transplant In Press; DOI: 10.12659/AOT.945249  

Most Viewed Current Articles

05 Apr 2022 : Original article   12,974

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   10,077

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   9,421

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   7,180

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358